论文部分内容阅读
[目的]观察血塞通联合奥扎格雷钠治疗急性脑梗死的临床疗效。[方法]将85例分为治疗组和对照组,对照组给予奥扎格雷钠80mg/日,治疗组在此基础上加用血塞通0.8g/日,连续14日。观察两组治疗前后临床神经功能缺损程度较治疗前有所改善(P<0.05),但治疗组改善更明显(P<0.05)。治疗14日后临床疗效评价,治疗组总有效率(87.5%)较对照组(67.5%)差异有显著性(P<0.05)。两组治疗后纤维蛋白原含量均比治疗前有显著下降(P<0.05)。治疗组与对照组比较有显著差异性(P<0.05)。[结论]血塞通联合奥扎格雷钠治疗急性脑梗死效果明显。
[Objective] To observe the clinical efficacy of Xuesaitong combined with ozagrel sodium in the treatment of acute cerebral infarction. [Method] 85 cases were divided into treatment group and control group. Ozagrel sodium 80 mg / day was given to the control group. Xuesaitong 0.8 g / day was added to the treatment group for 14 consecutive days. The degree of clinical neurological deficit in both groups before and after treatment was improved (P <0.05), but the improvement in the treatment group was more obvious (P <0.05). After 14 days of treatment, the total effective rate (87.5%) in the treatment group was significantly higher than that in the control group (67.5%) (P <0.05). The fibrinogen content in both groups after treatment was significantly lower than before treatment (P <0.05). There was significant difference between the treatment group and the control group (P <0.05). [Conclusion] Xuesaitong combined with ozagrel sodium has obvious effect on acute cerebral infarction.